Search

everythinglearnresearchcommunity

for

Search:↓

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

PCOS may be influenced by factors in the blood, not just the ovaries.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Spironolactone may help reduce hair loss in androgenic alopecia.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

Tattooing guidelines focus on safety, hygiene, and following rules.

The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Sarcoidosis can cause various skin issues, making diagnosis difficult.

Women with PCOS often have irregular periods, a higher chance of infertility and miscarriages, and may improve fertility with lifestyle changes and treatment.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Squarticles effectively deliver hair growth drugs to follicles and dermal papilla cells.

Jojoba oil is highly valued for its diverse medicinal and industrial uses.

Injecting a special gel with human protein particles can help hair grow.

Nanoparticles with more oleic acid improved the delivery and stability of the drug spironolactone.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The PCOSQ-50 is a valid and reliable questionnaire for measuring quality of life in Iranian women with PCOS.